TY - JOUR
T1 - Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen
AU - Cheng, L.
AU - Enomoto, T.
AU - Hirota, T.
AU - Shimizu, M.
AU - Takahashi, N.
AU - Akahoshi, M.
AU - Matsuda, A.
AU - Dake, Y.
AU - Doi, S.
AU - Enomoto, K.
AU - Yamasaki, A.
AU - Fukuda, S.
AU - Mao, X. Q.
AU - Hopkin, J. M.
AU - Tamari, M.
AU - Shirakawa, T.
PY - 2004/8
Y1 - 2004/8
N2 - Background: A recent report provided evidence that a disintegrin and metalloprotease domain 33 (ADAM33), a member of the ADAM family, is a novel susceptibility gene in asthma linked to bronchial hyper-responsiveness. However, there has been no investigation of the genetic role of ADAM33 variants in nasal allergy. Objective: The purpose of this study was to test the association between ADAM33 polymorphisms and Japanese cedar pollinosis (JCPsis), a most common seasonal allergic rhinitis in Japan. Methods: We conducted a case-control association study among a Japanese population, involving 95 adult individuals with JCPsis and 95 normal healthy controls. A total of 22 single-nucleotide polymorphisms (SNPs) in ADAM33 were genotyped using PCR-based molecular methods. Results: Six SNPs of ADAM33 gene, three in introns (7575G/A, 9073G/A and 12540C/T) and three in the coding region (10918G/C, 12433T/C and 12462C/T), were strongly associated with JCPsis (P = 0.0002-0.022 for absolute allele frequencies) and most of the SNPs were in linkage disequilibrium with each other. A higher frequency of the common alleles of these SNPs was noted for the subjects with JCPsis in comparison with healthy controls. We also identified a haplotype associated with the disease susceptibility. In addition, associations were found between ADAM33 polymorphisms and various cedar pollinosis phenotypes including clinical severity, eosinophil counts in nasal secretion and allergen-specific IgE levels in sera, but not total serum IgE levels. Conclusion: These results indicate that polymorphisms in the ADAM33 gene are associated with susceptibility to allergic rhinitis due to Japanese cedar pollen, but the functional relationship still needs clarification.
AB - Background: A recent report provided evidence that a disintegrin and metalloprotease domain 33 (ADAM33), a member of the ADAM family, is a novel susceptibility gene in asthma linked to bronchial hyper-responsiveness. However, there has been no investigation of the genetic role of ADAM33 variants in nasal allergy. Objective: The purpose of this study was to test the association between ADAM33 polymorphisms and Japanese cedar pollinosis (JCPsis), a most common seasonal allergic rhinitis in Japan. Methods: We conducted a case-control association study among a Japanese population, involving 95 adult individuals with JCPsis and 95 normal healthy controls. A total of 22 single-nucleotide polymorphisms (SNPs) in ADAM33 were genotyped using PCR-based molecular methods. Results: Six SNPs of ADAM33 gene, three in introns (7575G/A, 9073G/A and 12540C/T) and three in the coding region (10918G/C, 12433T/C and 12462C/T), were strongly associated with JCPsis (P = 0.0002-0.022 for absolute allele frequencies) and most of the SNPs were in linkage disequilibrium with each other. A higher frequency of the common alleles of these SNPs was noted for the subjects with JCPsis in comparison with healthy controls. We also identified a haplotype associated with the disease susceptibility. In addition, associations were found between ADAM33 polymorphisms and various cedar pollinosis phenotypes including clinical severity, eosinophil counts in nasal secretion and allergen-specific IgE levels in sera, but not total serum IgE levels. Conclusion: These results indicate that polymorphisms in the ADAM33 gene are associated with susceptibility to allergic rhinitis due to Japanese cedar pollen, but the functional relationship still needs clarification.
UR - http://www.scopus.com/inward/record.url?scp=4143132057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4143132057&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2222.2004.02008.x
DO - 10.1111/j.1365-2222.2004.02008.x
M3 - Article
C2 - 15298558
AN - SCOPUS:4143132057
SN - 0954-7894
VL - 34
SP - 1192
EP - 1201
JO - Clinical and Experimental Allergy
JF - Clinical and Experimental Allergy
IS - 8
ER -